SHELTON, CT / ACCESS Newswire / July 22, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that ...
Karyopharm (KPTI) downgraded to Hold amid weak XPOVIO sales, FDA setbacks, and mixed SENTRY data. Click here to read my most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results